Ultimately, to confirm the role of mTORC1 activity in CML differentiation, we generated tuberous sclerosis complex 2 (TSC2) KO cells (Fig. 4g and Supplementary Fig. 5i). Here, TSC2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.